Back to top

Latest News

3 August 2015

Double strength Copaxone available on the PBS

In March this year the Pharmaceutical Benefits Advisory Committee (PBAC), recommended a modified version of glatiramer acetate (Copaxone) for reimbursement on the Pharmaceutical Benefits Scheme. This medication for relapsing remitting MS became available on the PBS as of 1 August, 2015.


28 July 2015

Decision to reduce NDIS prices for group support overturned

MS Australia welcomes the announcement from the National Disability Services (NDS) today on the National Disability Insurance Agency (NDIA) reversing its decision to reduce National Disability Insurance Scheme (NDIS) prices for group-based community, social and recreational activities.


2 June 2015

Medikidz: Australian-first MS comic book for children launches

Global children’s healthcare education brand Medikidz - in collaboration with MS Australia and the Australian and New Zealand Association of Neurologists (ANZAN) – has launched an Australian-first educational comic designed to explain complex medical information about MS in a format that...

27 May 2015

World MS Day: A thousand ways to raise hope for MS

Boats, bikes, mountains, weights and tutus — say what?

Can you guess what connects these disparate events and splendid people?

At this very moment Andrew Potter is aboard the Oceans of Hope, a 67 foot sailing boat circumnavigating the globe.

Last weekend Justine Martin from...

21 May 2015

Catherine King welcomes Oceans of Hope

Over 23,000 people live with MS in Australia and more than two million worldwide.

Every year another 1,000 Australians are diagnosed with this cruel disease, most of them aged between 20 and 40, and despite great advances in treatment and care, it remains a disease without a cure.


20 May 2015

Bill Shorten welcomes Oceans of Hope to Sydney

On behalf of Federal Labor, please accept my congratulations and best wishes for World MS Day 2015. The arrival of Oceans of Hope is a wonderful way to commemorate and celebrate this important day.

A global circumnavigation by a crew that includes people living with multiple sclerosis is...

13 May 2015

Budget a mixed bag for people with MS

Last night’s Budget handed down by Treasurer Joe Hockey is a real mixed bag for people with Multiple Sclerosis, Acting CEO of MS Australia Deidre Mackechnie said today.

There are 23,000 people living with MS in Australia. There is currently no known cure for MS and living with the disease...

11 May 2015

Opinion piece: People with MS need a fair Budget

Here is an opinion piece that was issued by MS Australia ahead of this year’s Federal Budget announcements, setting out what people with MS need from a Federal Budget.

People with MS need a Fair Budget

There are 23,000 people living with MS in...

The Australian Greens Party
6 May 2015

MS Australia welcomes new Greens Leader

MS Australia welcomes the elevation of Richard Di Natale to the position of Leader of the Greens in the Commonwealth Parliament.

MS Australia CEO Debra Cerasa said "MS Australia has always enjoyed a progressive and productive relationship with the Australian Greens. We are especially...

30 March 2015

Lemtrada available on the Pharmaceutical Benefits Scheme

The Australian government has announced that new MS medication Lemtrada® (alemtuzumab) will be available on the Pharmaceutical Benefits Scheme (PBS) from 1st April 2015.

Lemtrada (alemtuzumab) was previously approved by the Therapeutic Goods Administration (TGA) in December 2013 for use...

9 March 2015

Dance For Health

A new health and fitness opportunity for those with multiple sclerosis is about to hit Sydney.

Dance For Health is inviting people with multiple sclerosis to join a complementary open movement class. It will be held on Friday 10 April at Sydney Dance Company.

Dance For Health...

25 February 2015

Injectable MS medication Plegridy to be listed on the PBS

Biogen Idec has announced that their new injectable medication PLEGRIDY  (peginterferon beta-1a) will be listed on the Pharmaceutical Benefits Scheme (PBS) for treatment of patients with relapsing-remitting multiple sclerosis from March 1.

Plegridy is a sub-cutaneous injection treatment...